arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

OPKO HEALTH, INC.

OPK
$1.32 ▼ -0.04 (-2.57%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
18 Visible periods
30 Metrics
Peer-ranked Benchmarks
Price Chart
35
Health
Poor
Bearish
auto_awesome

Analytical Summary

OPKO HEALTH, INC. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $991.5M
Dividend Yield
Revenue Growth -14.9%
Op. Margin -19.3%
ROIC -5.8%
FCF / Share $-0.24
Trailing P/E
Price / Book 0.8x
FCF Yield
Debt / Equity 0.27
info Valuation on last close. End-of-day price, Aug 6, 2026.

18-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$606.88M
↓ -14.9%
Net Income Profit after all expenses
$-225.68M
↓ -324.0%
Operating Margin Operating profit as % of sales
-19.3%
↑ +9.3% 10th
FCF / Share Free cash flow per share
$-0.24
↑ +10.1%
Long-Term Debt Long-term obligations
$343.97M
↓ -21.3%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
8
Returns
29
Financial Health
66
Cash Quality
53

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 18 years · 68 quarters